Generate a tailored SOP for Dr. Daniela Traini. Improve your application with a focused, well-structured draft.
Professor Daniela Traini is a recognized expert in Respiratory Science with over 20 years of experience in inhalation drug development, particularly focusing on particle engineering for drug delivery. She completed her PhD in Pharmaceutics at the University of Bath in 2005 and has since led research teams at the University of Sydney from 2005 to 2021 before joining Macquarie University in 2021. Her role as an NHMRC Investigator spans from 2020 to 2024, showcasing her commitment to advancing respiratory technologies. Traini has been involved in various significant projects, including the development of smart intranasal delivery systems for Alzheimer's treatment and RNA therapeutic delivery for brain cancer. She has contributed to the academic community through mentorship and leadership, receiving numerous prestigious awards, including an excellence award for postgraduate education in 2019 and a teaching award for outstanding mentoring in 2017. Her work is at the forefront of respiratory technology innovation, with active collaborations and projects that aim to transform drug delivery methods for improved patient outcomes.
Woolcock Institute of Medical Research • Sydney, Australia
Leading research in respiratory science and drug delivery technologies.
Ab Initio Pharma • Sydney, Australia
Overseeing operations and research initiatives in inhalation drug development.
University of Sydney • Sydney, Australia
Conducting advanced research in respiratory drug delivery systems.
Applied to Department of Business (MBA Program).